Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias

NCT02921477 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Dementia

Interventions

DRUG: bosutinib

Sponsor

Neurological Associates of West Los Angeles

Collaborators

[object Object]